TLSI Stock Analysis: Buy, Sell, or Hold?
TLSI - TriSalus Life Sciences, Inc. Common Stock
$4.43
-0.03 (-0.67%)
▼
5d:
+0.91%
30d:
+4.73%
90d:
-6.74%
BUY
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 12, 2026
3d
Get Alerted When TLSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TLSI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TLSI shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TLSI is currently trading at $4.43, which is considered fair relative to its 30-day fair value range of $4.14 to $4.59.
Technical Outlook: Technically, TLSI is in a strong downtrend. Immediate support is located at $4.25, while resistance sits at $4.72.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.20 (+106.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TLSI is in a strong downtrend. Immediate support is located at $4.25, while resistance sits at $4.72.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.20 (+106.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.14 -
$4.59
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 106.3% below Wall St target ($9.20)
Trading Range Analysis
30-Day Trading Range
$4.14 -
$4.59
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.25
Resistance Level
$4.72
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.84
Wall Street Target
$9.20
(+106.3%)
Revenue Growth (YoY)
59.8%
Profit Margin
-86.9%
Share & Embed Analysis
Last updated: May 08, 2026 3:56 PM ET
Data refreshes hourly during market hours. Next update: 4:56 PM
Data refreshes hourly during market hours. Next update: 4:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Mary T Szela
SELL
15944 shares
2026-03-17
Bryan F Cox
SELL
579 shares
2026-03-16
Jodi Devlin
SELL
273 shares
2026-03-16
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$394 | 53 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 58 HOLD |
